{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T06:04:23Z","timestamp":1783749863525,"version":"3.55.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02563","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T04:23:05Z","timestamp":1572495785000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus Disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Rebecca M.","family":"Broeckel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Haese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Dmitriev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig N.","family":"Kreklywich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"DeFilippis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhem","family":"Messaoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel N.","family":"Streblow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.4049\/jimmunol.0900255","article-title":"Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response","volume":"184","author":"Hoarau","year":"2010","journal-title":"J Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1741-7015-9-5","article-title":"Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study","volume":"9","author":"G\u00e9rardin","year":"2011","journal-title":"BMC Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e2137","DOI":"10.1371\/journal.pntd.0002137","article-title":"Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study","volume":"7","author":"Schilte","year":"2013","journal-title":"PLoS Negl Trop Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1093\/rheumatology\/kes015","article-title":"Impaired quality of life after chikungunya virus infection: a 2-year follow-up study","volume":"51","author":"Couturier","year":"2012","journal-title":"Rheumatology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1099\/vir.0.82858-0","article-title":"Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus","volume":"88","author":"Powers","year":"2007","journal-title":"J Gen Virol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e2921","DOI":"10.1371\/journal.pntd.0002921","article-title":"Arrival of chikungunya virus in the new world: prospects for spread and impact on public health","volume":"8","author":"Weaver","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.antiviral.2015.04.016","article-title":"Chikungunya: evolutionary history and recent epidemic spread","volume":"120","author":"Weaver","year":"2015","journal-title":"Antiviral Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1086\/600381","article-title":"Prophylaxis and therapy for Chikungunya virus infection","volume":"200","author":"Couderc","year":"2009","journal-title":"J Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"13878","DOI":"10.1128\/JVI.02666-13","article-title":"Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response","volume":"87","author":"Hawman","year":"2013","journal-title":"J Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"8213","DOI":"10.1128\/JVI.01032-14","article-title":"Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes","volume":"88","author":"Pal","year":"2014","journal-title":"J Virol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0005637","DOI":"10.1371\/journal.pntd.0005637","article-title":"Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques","volume":"11","author":"Broeckel","year":"2017","journal-title":"PLoS Negl Trop Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/S0140-6736(14)61185-5","article-title":"Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial","volume":"384","author":"Chang","year":"2014","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1128\/JVI.03453-13","article-title":"Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL\/6 mice","volume":"88","author":"Halleng\u00e4rd","year":"2014","journal-title":"J Virol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"E322","DOI":"10.3390\/v11040322","article-title":"Assessment of immunogenicity and neutralisation efficacy of viral-vectored vaccines against chikungunya virus","volume":"11","author":"L\u00f3pez-Camacho","year":"2019","journal-title":"Viruses."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1016\/S0140-6736(18)32488-7","article-title":"Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial","volume":"392","author":"Reisinger","year":"2019","journal-title":"Lancet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0006919","DOI":"10.1371\/journal.pntd.0006919","article-title":"Chikungunya as a paradigm for emerging viral diseases: evaluating disease impact and hurdles to vaccine development","volume":"13","author":"Rezza","year":"2019","journal-title":"PLoS Negl Trop Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1002142","DOI":"10.1371\/journal.ppat.1002142","article-title":"Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism","volume":"7","author":"Plante","year":"2011","journal-title":"PLoS Pathog."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1016\/j.vaccine.2013.05.059","article-title":"Deciphering the protective role of adaptive immunity to CHIKV\/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model","volume":"31","author":"Chu","year":"2013","journal-title":"Vaccine."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/infdis\/jiu014","article-title":"Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose","volume":"209","author":"Roy","year":"2014","journal-title":"J Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e2970","DOI":"10.1371\/journal.pntd.0002970","article-title":"A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice","volume":"8","author":"Weger-Lucarelli","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ajpath.2010.11.018","article-title":"A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence","volume":"178","author":"Morrison","year":"2011","journal-title":"Am J Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4049\/jimmunol.1202177","article-title":"A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice","volume":"190","author":"Teo","year":"2013","journal-title":"J Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"eaal1333","DOI":"10.1126\/scitranslmed.aal1333","article-title":"Fingolimod treatment abrogates chikungunya virus-induced arthralgia","volume":"9","author":"Teo","year":"2017","journal-title":"Sci Transl Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"eaah3438","DOI":"10.1126\/scitranslmed.aah3438","article-title":"Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis","volume":"9","author":"Miner","year":"2017","journal-title":"Sci Transl Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e3354","DOI":"10.1371\/journal.pntd.0003354","article-title":"Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection","volume":"8","author":"Poo","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"678","DOI":"10.4049\/jimmunol.1401833","article-title":"CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected mice","volume":"194","author":"Burrack","year":"2015","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1126\/science.1059742","article-title":"Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons","volume":"293","author":"Binder","year":"2001","journal-title":"Science."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1016\/j.vaccine.2009.04.015","article-title":"CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus","volume":"27","author":"Yun","year":"2009","journal-title":"Vaccine."},{"key":"B29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1099\/0022-1317-80-2-345","article-title":"Development and use of a 293 cell line expressing lac repressor for the rescue of recombinant adenoviruses expressing high levels of rabies virus glycoprotein","volume":"80","author":"Matthews","year":"1999","journal-title":"J Gen Virol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"14759","DOI":"10.1073\/pnas.94.26.14759","article-title":"Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome","volume":"94","author":"Messerle","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e1275","DOI":"10.1371\/journal.pntd.0001275","article-title":"A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus","volume":"5","author":"Tsuda","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1093\/nar\/gni035","article-title":"Simple and highly efficient BAC recombineering using galK selection","volume":"33","author":"Warming","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"Unit14E","DOI":"10.1002\/9780471729259.mc14e04s24","article-title":"Human cytomegalovirus: bacterial artificial chromosome (BAC) cloning and genetic manipulation","volume":"14","author":"Paredes","year":"2012","journal-title":"Curr Protoc Microbiol Chapter."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7285","DOI":"10.1128\/JVI.00373-09","article-title":"Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus","volume":"83","author":"Safronetz","year":"2009","journal-title":"J Virol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"13520","DOI":"10.1038\/ncomms13520","article-title":"Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months","volume":"7","author":"Pelliccia","year":"2016","journal-title":"Nat Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1016\/j.vaccine.2008.03.060","article-title":"Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus","volume":"26","author":"Muthumani","year":"2008","journal-title":"Vaccine."},{"key":"B37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.meegid.2015.01.017","article-title":"In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection","volume":"31","author":"Pratheek","year":"2015","journal-title":"Infect Genet Evol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1128\/JVI.78.5.2255-2264.2004","article-title":"Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses","volume":"78","author":"Karrer","year":"2004","journal-title":"J Virol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"13407","DOI":"10.1128\/JVI.77.24.13407-13411.2003","article-title":"Detailed analysis of the CD8+ T-cell response following adenovirus vaccination","volume":"77","author":"Yang","year":"2003","journal-title":"J Virol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1371\/journal.ppat.0040029","article-title":"A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease","volume":"4","author":"Couderc","year":"2008","journal-title":"PLoS Pathog."},{"key":"B41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/infdis\/jiq006","article-title":"The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation","volume":"204","author":"Wauquier","year":"2011","journal-title":"J Infect Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e84695","DOI":"10.1371\/journal.pone.0084695","article-title":"Identical strength of the T cell responses against E2, nsP1 and capsid CHIKV proteins in recovered and chronic patients after the epidemics of 2005-2006 in La Reunion Island","volume":"8","author":"Hoarau","year":"2013","journal-title":"PLoS ONE."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e527","DOI":"10.1371\/journal.pone.0000527","article-title":"Human muscle satellite cells as targets of Chikungunya virus infection","volume":"2","author":"Ozden","year":"2007","journal-title":"PLoS ONE."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1182\/blood-2007-02-062117","article-title":"Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines","volume":"110","author":"Tatsis","year":"2007","journal-title":"Blood."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.4049\/jimmunol.1203151","article-title":"Competition for antigen at the level of the APC is a major determinant of immunodominance during memory inflation in murine cytomegalovirus infection","volume":"190","author":"Farrington","year":"2013","journal-title":"J Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02563\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T04:23:07Z","timestamp":1572495787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02563\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2019.02563"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02563","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,31]]},"article-number":"2563"}}